Biofourmis
Biofourmis founder emerges with new startup OutcomesAI; partners SingHealth
Tech firm aims to increase capacity of existing nurses and care teams, reducing their time spent on administrative clinical tasks by almost 50%
Biofourmis axes staff again, including 45 in Singapore; healthtech vacating office here: sources
HEALTHTECH unicorn Biofourmis is conducting a second major round of layoffs affecting around 45 staff in Singapore and at least 85 staff globally, sources familiar with the matter told The Business Ti...
CEO to be replaced after healthtech unicorn Biofourmis lays off 120 staff
HEALTHCARE startup Biofourmis is searching for a new chief executive after its founder Kuldeep Singh Rajput abruptly stepped down on Wednesday (Aug 30), more than a month after the company laid off ab...
Neuroglee raises US$2.3m in pre-seed funding from Elsai and Biofourmis CEO
HEALTHTECH startup Neuroglee has secured US$2.3 million in pre-seed funding to advance its product pipeline for the treatment and management of patients at the early stage of Alzheimer's disease.
Series C funding sends Biofourmis to near-unicorn status
HOMEGROWN startup Biofourmis has raised US$100 million in a Series C equity round led by Softbank Vision Fund 2, catapulting the healthcare company to near-unicorn status in a matter of months.
Healthtech startup Biofourmis gets FDA approval for analytics engine
SINGAPORE healthtech startup Biofourmis, headquartered in Boston, has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its patient data-monitoring solution, it a...
Healthtech startup Biofourmis partners Novartis to tackle heart failure
SINGAPORE healthtech startup Biofourmis is collaborating with Swiss pharmaceutical giant Novartis to start a digital therapeutics programme for patients with heart failure in South-east Asia, it annou...
Biofourmis acquires Gaido Health, expands into oncology
DIGITAL therapeutics startup Biofourmis on Thursday said it has acquired oncology-focused patient monitoring platform Gaido Health, to expand its portfolio in the oncology space.
Openspace unveils mid-stage fund OSV+; adds ex-Disney executive as director
SINGAPORE-BASED venture firm Openspace Ventures on Monday announced its fourth fund, OSV+, focused on mid-stage tech investments.
Biofourmis' remote monitoring platform used by MOH for Covid-19 patients
A PLATFORM developed by Biofourmis, a digital therapeutics company working on personalised predictive care, is being deployed by the Ministry of Health (MOH) to remotely monitor Covid-19 patients.
